Home › Diffuse Large B-Cell Lymphoma › New York › Buffalo
Diffuse Large B-Cell Lymphoma clinical trials in Buffalo, NY
6 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RecruitingPhase 2
- Roswell Park Cancer Institute ( Site 0192), Buffalo
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
RecruitingPhase 2
- Roswell Park Cancer Institute, Buffalo
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Buffalo
- Acute Myeloid Leukemia19 studies
- Cancer (all types)19 studies
- Non-Small Cell Lung Cancer18 studies
- Lung Cancer16 studies
- Breast Cancer16 studies
- Ovarian Cancer13 studies
- Prostate Cancer11 studies
- Metastatic Cancer10 studies
- Multiple Myeloma10 studies
- Melanoma10 studies
- Obesity9 studies
- Endometrial Cancer8 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.